News
SATVI researcher Professor Tom Scriba and Stanley Kimbung Mbandi have co-authored an article titled "Immune correlates of tuberculosis disease and risk translate across species" appearing in the Science Translational Medicine journal.
Professor Tom Scriba and Dr Simon Mendelsohn have published a journal article titled: "Making headway towards biosignatures for incipient tuberculosis" appearing in the Lancet Respiratory Medicine.
The Prevention of Recurrence (POR) Consortium has been awarded a substantial grant from the European & Developing Countries Clinical Trial Partnership (EDCTP) which will support a clinical trial in South Africa and Tanzania of a new and promising tuberculosis (TB) vaccine candidate H56:IC31, developed by the Statens Serum Institute (SSI).
Professor Mark Hatherill has co-authored a journal article titled: "Preferred product characteristics for therapeutic vaccines to improve tuberculosis treatment outcomes: Key considerations from World Health Organisation consultations" appearing in the Vaccine journal.
Pages
Worcester Site Office:
SATVI Project Office, University of Cape Town, Brewelskloof Hospital, Haarlem Street, WORCESTER, 6850.
Tel: +27 23 346 5400
Fax: +27 23 346 5406
Email: Field Site Manager
Google maps: Click here GPS: 33.620455, 19.458576
Map to Worcester Field Office